Virtual Medicinal Product (VMP)
-
Dipotassium clorazepate 7.5mg capsules
Name Details
Current Name
Dipotassium clorazepate 7.5mg capsules
|
Start Date
22-12-2004
|
End Date
|
Previous Name
Clorazepate dipotassium 7.5mg capsules
|
Start Date
29-10-2004
|
End Date
21-12-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Invalid to prescribe in NHS primary care
- Controlled Drug Category
- Schedule 4 (CD Benz)
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05BA05
BNF |
Current BNF
04010200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04010200
|
Start Date
01-02-2005
|
End Date
02-05-2006
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42128611000001109 |
04-08-2023 |
|
321276002 |
19-09-2003 |
03-08-2023 |
VMP Ingredients
Name
Dipotassium clorazepate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
7.5
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information